Development of a poly(vinyl alcohol)/lysine electrospun membrane-based drug delivery system for improved skin regeneration by Sequeira, Rosa S. et al.
Contents lists available at ScienceDirect
International Journal of Pharmaceutics
journal homepage: www.elsevier.com/locate/ijpharm
Development of a poly(vinyl alcohol)/lysine electrospun membrane-based
drug delivery system for improved skin regeneration
Rosa S. Sequeiraa, Sónia P. Miguela, Cátia S.D. Cabrala, André F. Moreiraa, Paula Ferreirab,
Ilídio J. Correiaa,b,⁎
a CICS-UBI – Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal
b CIEPQPF – Departamento de Engenharia Química, Universidade de Coimbra, Rua Silvio Lima, 3030-790 Coimbra, Portugal







A B S T R A C T
Nanofiber-based wound dressings are currently being explored as delivery systems of different biomolecules for
avoiding skin infections as well as improve/accelerate the healing process. In the present work, a nanofibrous
membrane composed of poly(vinyl alcohol) (PVA) and lysine (Lys) was produced by using the electrospinning
technique. Further, anti-inflammatory (ibuprofen (IBP)) and antibacterial (lavender oil (LO)) agents were in-
corporated within the electrospun membrane through blend electrospinning and surface physical adsorption
methods, respectively. The obtained results demonstrated that the PVA_Lys electrospun membranes in-
corporating IBP or LO displayed the suitable morphological, mechanical and biological properties for enhancing
the wound healing process. Moreover, the controlled and sustained release profile attained for IBP was appro-
priate for the duration of the wound healing inflammatory phase, whereas the initial burst release of LO is
crucial to prevent wound bacterial contamination. Indeed, the PVA_Lys_LO electrospun membranes were able to
mediate a strong antibacterial activity against both S. aureus and P. aeruginosa, without compromising human
fibroblasts viability. Overall, the gathered data emphasizes the potential of the PVA_Lys electrospun membranes-
based drug delivery systems to be used as wound dressings.
1. Introduction
After a skin injury occurs, a complex wound healing process is im-
mediately initiated to re-establish, as soon as possible, skin structure
and functions (Gurtner et al., 2008). Up to now, different types of
dressing materials (e.g. gauzes, sponges, gels, creams) have been used to
cover the wound site, in order to provide protection against external
harmful agents, avoid patient dehydration, and promote the skin re-
generation process (Pereira et al., 2013). Furthermore, there are gels
and creams incorporating drugs (Mederma®, Contractubex®, Cybe-
le®Scagel, Erasé gel, etc) that are used in the clinic to accelerate/
ameliorate the wound healing process (Gizaw et al., 2018; Miguel et al.,
2018; Sidgwick et al., 2015). However, these dressings require periodic
replacement and display a limited therapeutic outcome. Additionally,
the frequent wound management can often be painful for the patient as
well as cost- and labour-intensive for the healthcare system (Gizaw
et al., 2018; Miguel et al., 2018). To surpass these handicaps, re-
searchers have been devoted to develop advanced regenerative dres-
sings, that: i) protect the wound; ii) are biodegradable; iii) are
biocompatible; iv) promote the wound exudate absorption and v) are
able to provide a sustained release of drugs that enhance the wound
healing process as well as decrease patient pain (Gizaw et al., 2018;
Miguel et al., 2018; Miguel et al., 2019a).
Electrospun nanofiber-based wound dressings have arisen as one of
the most promising therapeutic solutions for wound healing manage-
ment, since they exhibit structural features that are quite similar to
those presented by the native skin’s extracellular matrix (ECM) (Miguel
et al., 2017; Miguel et al., 2018; Miguel et al., 2019b; Thakkar and
Misra, 2017). Moreover, they present a high surface-to-volume ratio
that provides more space for cell attachment as well as a tuneable
porosity that allows the control over the wound site humidity and nu-
trients exchange (Miguel et al., 2018). Further, the excellent mechan-
ical properties exhibited by electrospun membranes guarantee that they
can endure the mechanical forces during its handling and the re-
generation process (Akduman et al., 2016; Chou et al., 2015; Thakkar
and Misra, 2017). Additionally, electrospun nanofibers can act as drug
delivery systems (Akduman et al., 2016; Braghirolli et al., 2014; Miguel
et al., 2019a) that exhibit efficient/sustained drug release profiles,
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leading to a reduction in the frequency of the treatments’ topical ap-
plication. Besides that, drug incorporation on nanofibers can be
achieved through different methods (e.g. blend, co-axial, physical ad-
sorption, and chemical immobilization) rendering them the capacity to
mediate the delivery of different biomolecules with specific release
profiles (Im et al., 2010; Miguel et al., 2018; Miguel et al., 2019a). The
physical adsorption method is commonly associated with burst releases,
while the co-axial electrospinning enables a more controlled and sus-
tained release profile (Im et al., 2010; Zamani et al., 2013). Sergio
Torres-Giner and colleagues verified that the coaxial PLA-collagen fi-
bers unveiled a more controlled release profile of gentamicin (41% after
24 h) than the blend PLA-collagen fibers (98% of gentamicin was re-
leased after 24 h) (Torres‐Giner et al., 2012). On the other side, Mon-
teiro et al. observed that the release profile of gentamicin covalently
immobilized at the surface of chitosan nanofibers meshes showed an
initial burst release (about 1mg of gentamicin was released after 10 h of
incubation) (Monteiro et al., 2015). In this field, there are several re-
ports addressing the electrospun membranes applying different meth-
odologies to incorporate antimicrobial (e.g. antibiotics, silver-based
materials, and natural extracts) and biological (e.g. growth factors, vi-
tamins and anti-inflammatory drugs) molecules, which will allow to
obtain distinct release profiles, as extensively reviewed by Miguel et al.
(2019a).
Herein, a multifunctional electrospun membrane able to incorporate
both biological (an anti-inflammatory drug) or antimicrobial (a plant
extract) compounds was produced. To accomplish that, Poly(vinyl al-
cohol) (PVA) and Lysine (Lys) were combined. The PVA is a synthetic
polymer used in different tissue engineering applications, due to its
hydrophilicity, good chemical resistance, biocompatibility, viscoelasti-
city and excellent mechanical performance (Jatoi et al., 2019; Majd
et al., 2016). In recent works, the applicability of the PVA-based bio-
materials in drug delivery and wound healing applications has been
demonstrated (Mohseni et al., 2019; Saviano et al., 2019; Shamloo
et al., 2018). In turn, Lys is an aminoacid that can promote cell adhe-
sion and proliferation as well as tissue regeneration at the biomaterial
interface. In the biological media, the amine groups available on Lys
molecule are protonated, thus facilitating its interaction with the ne-
gatively-charged cell membrane (Mekhail et al., 2014). In a previous
study, Mahanta and Valiyaveettil produced electrospun PVA mem-
branes chemically modified with Lys to be applied in the extraction of
nanosized contaminants from the aqueous environment (Mahanta and
Valiyaveettil, 2011). Moreover, Amariei and co-workers incorporated
the antimicrobial polypeptide ε-poly(l-lysine) (ε-PL) into poly(acrylic
acid) (PAA)/PVA electrospun membranes through electrostatic inter-
actions to create a wound dressing (Amariei et al., 2018). However, in
this work, the Lys and PVA were combined in a polymeric solution,
before the electrospinning process be performed, to improve the bio-
logical properties of the electrospun membranes. Furthermore, to ob-
tain distinct drug release profiles, different drug incorporation methods
were used in order to tailor the action of each biomolecule to a specific
time frame. For instance, the inflammation phase occurs 1–3 days after
injury, and consequently, the release profile of anti-inflammatory drugs
must be adjusted to this time-frame (Hart, 2002; Morgado et al., 2014).
On the other hand, the antimicrobial molecules should be released to
the wound site immediately after the dressing application to avoid any
bacterial contamination (Guo and Di Pietro, 2010; Simões et al.,
2018b). In this study, it was studied and optimized the release profile of
an anti-inflammatory molecule (ibuprofen (IBP), which was entrapped
in the nanofibers through blend electrospinning, and an antimicrobial
agent (Lavender oil (LO)), which was incorporated in the nanofibers by
physical adsorption. IBP is a non-steroidal anti-inflammatory drug
(NSAID) that inhibit the two isoforms of cyclooxygenase (COX-1 and
COX-2), which are involved in the biosynthesis of prostaglandins (pro-
inflammatory molecules) (Morgado et al., 2014; Morgado et al., 2017).
The anti-inflammatory performance of IBP was previously evaluated in
full-thickness wounds by Mohiti-Asli et al., which reported that the PLA
nanofibrous membranes containing 20% of IBP supported the wound
closure (60% wound contraction after 14 days) (Mohiti‐Asli et al.,
2017). On the other side, the LO is one natural product extracted from
lavender plant species such as Lavandula latifolia, Lavandula stoechas,
and Lavandula angustifolia, displaying excellent antimicrobial and an-
tioxidant properties (Balasubramanian and Kodam, 2014; Danh et al.,
2012; Predoi et al., 2018).
The experimental data gathered in this study supports the applica-
tion of the PVA_Lys multifunctional electrospun membrane as a tem-
porary support for cell attachment, proliferation, and hence the skin
regeneration process. In addition, the release profiles of the anti-in-
flammatory drug (IBP) and the antimicrobial compound (LO) obtained
herein are suitable to achieve an enhanced healing process.
2. Material and methods
2.1. Materials
Fetal bovine serum (FBS) free from any antibiotic was purchased
from Biochrom AG (Berlin, Germany). Normal human dermal fibro-
blasts (NHDF) cells were acquired from PromoCell (Labclinics, S.A.,
Barcelona, Spain). 3-(4,5-dimethylthiazol- 2-yl)-5-(3-carboxymethox-
yphenyl)-2 (4-sulfophenyl)-2H-tetrazolium (MTS) was bought from
Promega (Madison, WI, USA). L-lysine (98%, Mw=146,19 g/mol) was
obtained by Acros organics (China). Ibuprofen (IBP) was bought by TCI
(Tokyo Chemical Industry. Lavender oil (LO) was acquired by
Keypharm (Belgium). Dulbecco's modified eagle's medium (DMEM-
F12), Poly(ethylene oxide) (Mw=300,000 g/mol), Poly(vinyl alcohol)
(Mw=89,000–98,000 g/mol) 99% hydrolyzed, ethylenediaminete-
traacetic acid (EDTA), glutaraldehyde, LB Broth, phosphate-buffered
saline solution (PBS), 2,2-diphenly-1-picrylhydrazyl (DPPH), Triton X-
100 and trypsin were purchased from Sigma-Aldrich (Sintra, Portugal).
Quant-iT Pico Green dsDNA assay kit and Hoechst 33342® were ob-
tained from ThermoFisher Scientific (Waltham, MA, USA).
Staphylococcus aureus clinical isolate (S. aureus) ATCC 25923 and
Pseudomonas aeruginosa (P. aeruginosa) obtained from a human sample
were used as models of prokaryotic organisms to evaluate the bacter-
icidal activity exhibited by the produced membranes. Propidium iodide
buffer and WGA-Alexa 594® conjugate were gotten from Invitrogen
(Carlsbad, California, EUA) and Calcein AM was supplied by
Calbiochem (Merck Millipore, Oeiras, Portugal). A Milli-Q Advantage
A10 ultrapure Water Purification System (0.22 μm filtered; 18.2 MΩ/
cm at 25 °C) was used to obtain double deionized and filtered water.
2.2. Methods
2.2.1. Production of electrospun membranes
The electrospun membranes were produced by using a conventional
electrospinning apparatus. This equipment was composed by a high
voltage source (Spellman CZE1000R, 0–30 kV), a precision syringe
pump (KDS-100), a plastic syringe with a stainless-steel needle (21
Gauge), and an aluminum foil connected to a copper collector.
Initially, a PVA solution 9% (w/v) was dissolved in Milli-Q water in
90 °C under stirring for 1 h. Subsequently, the temperature was reduced
to 60 °C and then the L-lysine, at a concentration of 12.5mg/mL, was
added to the solution and mixed under magnetic stirring for 30min.
Lastly, 2 mL of PEO solution (8% w/v) were added to obtain a solution
viscosity that is suitable for the electrospinning process. After that,
10mL of the solution were loaded into the syringe, and electrospun
using a constant flow rate (1mL/h), a working distance of 12 cm, and
an applied voltage of 30 kV, resulting in PVA_Lys membrane.
In turn, the PVA_Lys_IBP membrane was obtained through the ad-
dition of IBP (at 1mg/mL) to the PVA_Lys solution before the electro-
spinning process. On the other side, the LO was adsorbed to the surface
of the PVA_Lys membrane by exploring the electrostatic interactions
that occur between the positively charged amine groups of Lys and the
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electronegative groups (e.g. acetate, aldehyde, and terpenoid moieties)
found in LO. For that purpose, 15 µL of LO (1.3 mg/mL in ethanol
(99.99%)) were placed at the PVA_Lys membrane’ surface (0.79 cm2)
and incubated at 50 °C, under vacuum, during 1 h, yielding to
PVA_Lys_LO membrane. The IBP and LO concentrations were selected
based on the cell viability data (please see Fig. S1).
2.2.2. Characterization of the solutions’ properties and membranes’
morphology
The viscosity of polymer solutions (PVA_Lys, PVA_Lys_PEO, and
PVA_Lys_PEO_IBP) were measured by using a rotational viscometer
(Brookfield, DVT3TRVCP), using a spindle speed of 20 rpm at 27.7 °C. A
CP-40 cone-plate measuring system was used. All rheological mea-
surements were performed in triplicate to ensure reproducibility.
In turn, the conductivity of polymeric solutions (n= 3) was de-
termined by using a conductivity meter (FiveEasy Cond meter F30,
Mettler Toledo, Malaysia), at 27.7 °C (Son et al., 2004). The solutions’
surface tension values were determined by using a PC controlled KSV
Sigma 70 tension balance, which employs the Du–Noüy ring detach-
ment method taking into account the Huh and Mason correction for
interface distortion.
Further, the produced membranes were also analyzed by Scanning
electron microscopy (SEM) to characterize their morphology and the
fibers’ diameter. To accomplish that, the samples were assembled onto
aluminum stubs using Araldite glue and sputter-coated with gold using
a Quorum Q150R ES sputter coater (Quorum Technologies Ltd.,
Laughton, East Sussex, UK). The SEM images were obtained using the
Hitachi S-3400 N Scanning Electron Microscope (Hitachi, Tokyo,
Japan), at an accelerating voltage of 20 kV. The nanofibers’ diameters
were measured using an image analysis software – Image J (Scion
Corp., Frederick, MD) (Simões et al., 2018a).
2.2.3. Attenuated total reflectance-Fourier transform infrared spectroscopy
analysis
To characterize the chemical composition of the membranes, atte-
nuated total reflectance-Fourier transform infrared spectroscopy (ATR-
FTIR) analysis was used. The membranes’ spectra were obtained with
an average of 128 scans, a spectral width ranging from 4000 and
400 cm−1 and a spectral resolution of 32 cm−1, using a Nicolet iS10
FTIR spectrophotometer (Thermo Scientific, Waltham, MA, USA). In
addition, the membranes raw materials were also subjected to spectral
analysis for comparative purposes.
2.2.4. Characterization of the mechanical properties of the membranes
The mechanical properties of the electrospun membranes were
evaluated using a Shimadzu AG-X Tensile Testing Machine (Tokyo,
Japan), at room temperature (RT), under wet and dry conditions, ac-
cordingly to the guidelines established by the Standard Test Method for
Tensile Properties of Polymer Matrix Composite Materials (ASTM
standard D3039/D3039 M) (Morgado et al., 2014).
To perform this assay, samples (n=5) with a width of 2 cm, gauge
length of 6 cm and thickness ranging from 0.41 to 0.52mm were used.
The length between the clamps was set to 2 cm and the speed of testing
was set to 20mm/min. For the wet conditions, the membranes were
previously immersed in a PBS solution (pH=5.5), over 2 h and at
37 °C. Load-extension data was recorded and the membranes’ stress–-
strain curve was obtained through the Eqs. (1) and (2), respectively:






where F is the applied force; A is the cross-sectional area; Δl is the
change in length, and L is the length between the clamps.
2.2.5. Determination of the membranes’ porosity
The total porosity of the membranes was evaluated by using a liquid
displacement method described elsewhere (Miguel et al., 2017). For
this assay, five specimens were weighed and then immersed in absolute
EtOH during 1 h. Then, the samples were re-weighted and the mem-








where Ws and Wd represent the swollen and dry weights of the mem-
brane, respectively. The D ethanol is the density of the ethanol at RT and
Vmembrane is the volume of the swollen membrane.
2.2.6. Evaluation of the membranes’ wettability
The wettability of the membranes was characterized by determining
the water contact angle (WCA) at their surfaces. To accomplish that, the
WCA was measured using the Data Physics Contact Angle System OCAH
200 apparatus, operating in static mode, at RT (Miguel et al., 2019b).
This assay consisted on the deposition of water drops (4 µL) at different
locations of the electrospun membranes’ surface (n=5).
2.2.7. Water vapor transmission rate (WVTR)
The water vapor diffusion through the membranes was determined
as reported elsewhere (Antunes et al., 2015). Briefly, the membranes
(n= 5) were used to seal the opening of a glass test tube (1.77 cm2)
containing 10mL of ultrapure water. To prevent non-specific water
evaporation, parafilm tape was used to fix the membrane in a glass
tube. Posteriorly, the membranes were incubated at 37 °C and the
amount of evaporated water was measured by monitoring the weight





Water Vapor Transmission Rate loss (4)
where Wloss is the daily weight loss of water and A is the area of the
tube opening.
2.2.8. Evaluation of the membranes’ swelling capacity
The swelling capacity of the produced membranes was determined
by immersing them in a PBS solution at pH 5 (pH of native skin) or pH 8
(pH displayed by injured skin), at 37 °C under stirring (40 rpm) (Miguel
et al., 2019b; Simões et al., 2018a). After, the excess of PBS was re-
moved with a filter paper, the samples (n=5) were weighted. In turn,
the swelling ratio was calculated using Eq. (5):




where Wt is the final weight and W0 is the initial weight of the mem-
branes.
2.2.9. Characterization of the membranes’ biodegradation profile
The degradation profile of the membranes was monitored by im-
mersing the samples in PBS, under stirring (40 rpm), at 37 °C. After 1, 3
and 7 days, the membranes (n= 5) were removed from the solutions,
fully dried and weighed. Then, the degradation percentage was calcu-
lated at each time through Eq. (6):
=
−




where Wi corresponds to the initial weight of the sample and Wt to the
weight of the sample at time t.
2.2.10. Evaluation of the membranes’ antioxidant capacity
The antioxidant activity of the membranes was evaluated through
the 2-diphenly-1-picrylhydrazyl (DPPH) radical scavenging assay, as
previously described in the literature (Miguel et al., 2019b; Simões
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et al., 2018a). To perform this assay, membrane samples (5 mg; n= 5)
were immersed in 3mL of DPPH solution (100 µM) in methanol and
incubated in a dark room, at RT during 30min. Afterward, the absor-
bance of each mixture was recorded using a microplate reader (Biorad
xMark microplate spectrophotometer), at 517 nm. The antioxidant ac-
tivity was then calculated using the Eq. (7):
=
−




where Ac and As represent the control and sample absorbance values,
respectively.
2.2.11. Evaluation of the IBP and LO encapsulation and loading efficiencies
The study of the IBP and LO encapsulation and loading efficiencies
was performed according to the method described by Miguel et al.
(2019b). The PVA_Lys_IBP and PVA_Lys_LO membranes (n=5) were
subjected to total degradation, through their immersion in hot water,
under sonication, for 2 h. Then, the samples were centrifuged at 18 000
g for 10min in order to obtain the supernatant. The supernatant ab-
sorbance was recorded using a Thermo Scientific Evolution 201 UV–vis
spectrophotometer, at 264 and 223 nm, for IBP and LO, respectively.
After that, the IBP and LO concentrations were determined using
standard calibration curves for IBP (y=1.4263x+0.0196,
R2=0.999) and for LO (y= 1.3833x+ 2.6952, R2=0.996). The en-
capsulation efficiency (EE) and loading efficiency (LE) for both bioac-












(%) 100i s (9)
where Wi is the total amount of IBP or LO added for loading, Ws is the
amount of compound in the supernatant, and Y is the total dry weight
of PVA_Lys_IBP and PVA_Lys_LO membranes.
2.2.12. In vitro IBP and LO release profile and analysis of the drug-release
kinetics
The amount of IBP and LO released at two pHs values (pH 5 and pH
8) was determined following the protocols already described in the
literature (Balasubramanian and Kodam, 2014; Miguel et al., 2019b;
Morgado et al., 2014). Briefly, the PVA_Lys_IBP and PVA_Lys_LO
membranes (15mg) were incubated at 37 °C under stirring (40 rpm)
with 1mL of PBS at pH 5 and 8 (n= 5). Then, at specific timepoints,
the samples were centrifugated (at 18,000g, for 10min) and the su-
pernatant’ absorbance was measured.
2.2.13. Characterization of the biological properties of the produced
membranes
2.2.13.1. Evaluation of cell viability and proliferation in contact with
electrospun membranes. The membranes’ biocompatibility was
characterized through an MTS assay, according to the ISO
10993–5:2009 (Biological evaluation of medical devices- Part 5: Tests
for in vitro cytotoxicity). To accomplish that, the produced membranes
(n=5) with sizes inferior to 10% of the well area, were placed into 96-
well plates and then sterilized under UV irradiation (254 nm, ≈ 7 mW
cm−2) during 1 h. Then, NHDF cells were seeded (cell passage between
15 and 20) at a density of 10×103 cells per well and incubated at
37 °C, in an incubator with a 5% CO2 humidified atmosphere. After 1, 3,
and 7 days of incubation, the medium of each well was removed and
replaced by a mixture of 100 μL of fresh culture medium and 20 μL of
MTS/PMS (phenazine methosulfate) reagent solution. Following 4 h of
incubation (at 37 °C, in a 5% CO2 atmosphere), the samples’ absorbance
was measured at 490 nm using a microplate reader (Biorad xMark
microplate spectrophotometer). Further, the positive control (K+) and
negative control (K−) were also used, which correspond to the cells
incubated with ethanol (70%) and cells incubated only with culture
medium, respectively.
2.2.13.2. dsDNA quantification. The NHDF proliferation in contact with
the membranes was also evaluated by measuring the dsDNA content
using a Quant-iT PicoGreen dsDNA Assay kit, as reported in the
literature (Miguel et al., 2017; Miguel et al., 2019b; Simões et al.,
2018a). Initially, the cells were placed in contact with the produced
membranes (n= 5) and after 1, 3 and 7 days of incubation, the cell lysis
was induced by adding Triton X-100 (1× ) to the wells during 1 h.
Then, the membranes were transferred into a 1.5 mL Eppendorfs and
subjected to a freeze–thaw cycle. Posteriorly, the samples were
sonicated and centrifuged at 18,000 g, for 15min, to obtain the
supernatant. After, 100 μL of supernatant was added to an equal
volume of PicoGreen solution in TE buffer (1× ). Lastly, the plate
was incubated in the dark for 10–15min and the fluorescence was
measured at excitation and emission wavelengths of 485 nm and
535 nm using a microplate reader. To quantify the dsDNA
concentrations, a calibration curve was determined using samples
with known concentrations of dsDNA.
2.2.13.3. Live/dead assay. The presence of viable and dead cells on the
produced membranes was monitored by using the Live/Dead assay
(Miguel et al., 2019b; Simões et al., 2018a). For that purpose, cells
(10×103 cells/mL) were seeded in contact with membranes (n=3),
in μ-Slide 8 well Ibidi imaging plates (Ibidi GmbH, Germany). Cells
seeded only with culture medium were used as the negative control
(K−), while those treated with Triton X-100 were used as the positive
control (K+). After 1, 3 and 7 days, samples were stained with Calcein
(2 μM) and Propidium iodide (15mM), following the instructions of the
manufacturer. Then samples were imaged with a confocal laser
scanning microscope (CLSM, Zeiss, Oberkochen, Germany) and
processed in the Zeiss Zen 2010 software (Zeiss, Oberkochen,
Germany).
2.2.13.4. Characterization of cell proliferation through confocal
microscopy analysis. The cell distribution and proliferation at the
electrospun membranes’ surface was evaluated by CLSM. To perform
that, cells (10x103 cells/mL) were seeded in μ-Slide 8 well Ibidi imaging
plates (Ibidi GmbH, Germany) in contact with membranes (n=3).
After 1 and 3 days of incubation, the cells were stained with the WGA-
Alexa 594® conjugate (5 µM) and Hoechst 33342® (2 μM), to label the
cytoplasm (red) and cell nucleus (blue), respectively (Figueira et al.,
2016). The 3D reconstruction and the image analysis were performed
using Zeiss Zen 2010 software (Zeiss, Oberkochen, Germany).
2.2.14. Evaluation of the produced membranes’ antimicrobial activity
Membranes’ antibacterial performance was studied through the
determination of the inhibition area produced by the membranes when
in contact with S. aureus or P. aeruginosa (Miguel et al., 2017; Miguel
et al., 2019b). Briefly, 200 μL of bacteria medium containing 1× 108
CFU/mL of S. aureus or P. aeruginosa were inoculated in LB agar plates.
Then, circular samples of the membranes (1 cm of diameter; n= 3)
were placed in the plate and then incubated for 24 h, at 37 °C. The
percentage of inhibition area was calculated using Eq. (10):
=




where, Ai and A0 represent the inhibition area and the area of the
membranes’ disc, respectively.
In addition, the antibacterial effect of the membranes against S.
aureus and P. aeruginosa was also evaluated by quantifying the colony-
forming units. Briefly, 50mg of each membrane sample (n=3) was
added to 10mL of LB broth containing 1×105 CFU/mL of early mid-
log phase bacteria culture and then incubated at 37 °C, for 24 h. After
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the incubation period, serial dilutions were prepared and 100 μL of
bacterial samples were transferred into LB agar plates and incubated for
24 h, at 37 °C. The bacterial colonies were then counted and defined as
CFU/mL (Miguel et al., 2017; Miguel et al., 2019b). The antibacterial
efficiency of the membranes was calculated through Eq. (11):
=
−




where N0 and N represent the CFU/mL of the control and the experi-
mental group, respectively.
2.2.15. Characterization of biological properties of the membranes through
SEM analysis
The cellular adhesion and biofilm formation at the PVA_Lys,
PVA_Lys_IBP and PVA_Lys_LO membranes’ surface (n= 3) were char-
acterized through SEM analysis. Initially, samples containing cells or
bacteria were fixed with 2.5% (v/v) glutaraldehyde for 15min and
30min, respectively. Then, samples were frozen during 1–2 h and
freeze-dried for 3 h (for samples containing cells) and 6 h (for samples
with bacteria) (Cabral et al., 2019; Miguel et al., 2019b). Lastly, the
samples were prepared for SEM analysis, according to the protocol
previously described in Section 2.2.2.
2.2.16. Statistical analysis
The statistical analysis of the obtained results was performed using
one-way analysis of variance (ANOVA), with the Newman-Keuls post
hoc test. A p value lower than 0.05 (p < 0.05) was considered statis-
tically significant.
3. Results and discussion
3.1. Characterization of the morphological and physicochemical properties
of produced nanofibrous membranes
The advances in the nanotechnology area highlighted the promising
properties of the electrospun nanofibers to be used as a drug delivery
systems (Goyal et al., 2016; Miguel et al., 2019a). Indeed, the appli-
cation of the nanofibrous carriers allows a site-specific release of the
drugs, reducing the total drug concentration required to exert the
therapeutic effect, as well as minimize the associated side effects (Chou
et al., 2015). Herein, a PVA_Lys electrospun membrane-based drug
delivery system was produced, in which ibuprofen (IBP) or lavender oil
(LO) were incorporated, by using blend electrospinning and surface
physical adsorption, respectively. The viscosity, electrical conductivity
and surface tension of the polymeric solutions were determined (for
further details see Table 1). As expected, the PEO addition improved all
parameters, making possible the electrospinning of the PVA_Lys solu-
tion. On the other side, the IBP incorporation promoted a decrease on
the viscosity, electrical conductivity and surface tension values of the
blend solution.
In addition, the morphological properties of the produced mem-
branes were investigated through SEM analysis and the fibers’ diameter
were assessed by performing SEM images analysis using ImageJ soft-
ware (as seen in Fig. 1). The obtained results showed that the electro-
spun membranes displayed a randomly oriented mesh composed of
highly interconnected fibers with a bead-free smooth surface.
Moreover, the PVA_Lys, PVA_Lys_IBP, and PVA_Lys_LO fibers had a
mean diameter value of 474.22 ± 144.85 nm, 385.03 ± 108.21 nm
and 487.14 ± 155.81 nm, respectively. Such results show that that the
incorporation of IBP promotes a decrease on the fibers’ diameter when
compared with PVA_Lys membrane, while the LO inclusion did not
induce any noticeable changes on the fibers’ size. Such differences may
be related to the method used for the therapeutics loading (blend or
surface adsorption), the establishment of hydrophobic interactions be-
tween the IBP and the PVA_Lys, or even by the decrease on the solution
viscosity, surface tension, and electrical conductivity upon the IBP in-
corporation (Tungprapa et al., 2007; Zeng et al., 2003). Similar results
were previously reported by Pires et al., who observed a decrease in the
poly(trimethylene carbonate‐co‐ε‐caprolactone) nanofibers diameter
from 1.09 ± 0.10 µm (for non-loaded fibers) to 0.84 ± 0.08 µm (for
fibers loaded with IBP 5%) (Pires et al., 2016). In a similar way, Liu
et al. also noticed that the mean fiber diameter decreased by raising the
IBP concentration, ie, 1.45 ± 0.71mm (without IBP),
1.40 ± 0.52mm (2% IBP), 1.32 ± 0.67mm (6% IBP) and
1.25 ± 0.59mm (10% IBP) (Liu et al., 2012).
On the other side, the incorporation of LO into PVA_Lys nanofibers
through the surface physical adsorption technique allowed the pro-
duction of the PVA_Lys_LO membrane displaying a more irregular and
rougher surface. This methodology has been previously used to im-
mobilize growth factors and heparin on the nanofibers’ surface without
inducing significant differences on the nanofibers morphology
(Rajangam et al., 2006). Additionally, it is worth to notice that all the
electrospun membranes presented nanofibers with diameters that are
within the range of collagen fibrils found at the ECM (50–500 nm),
increasing its structural similarity with the native skin tissue (Figueira
et al., 2016; Miguel et al., 2017; Miguel et al., 2018).
Furthermore, the chemical composition of the membranes was as-
sessed through ATR-FTIR analysis. The spectra of raw materials used for
membranes’ production are presented in Fig. 2A. The PVA spectrum
presents its characteristics peaks at 3299 cm−1 (O–H stretching),
2917 cm−1 (asymmetric CH2 stretching), 1427 cm−1 (CH-O–H
stretching), 1085 cm−1 (C-O stretching), and 838 cm−1 (C–C
stretching) (Najafi et al., 2018; Santos et al., 2014). In turn, the Lys
amide (I) and amide (II) vibrations are clearly visible at 1572 and
1511 cm−1, respectively (Zhai et al., 2002; Zhao et al., 2003). Further,
it is also possible to observe the characteristic band (CH2) of PEO in the
region between 2900 cm−1 and 2850 cm−1 (Miguel et al., 2017). On
the other side, Fig. S2 displays the characteristic peaks of the com-
pounds incorporated into PVA_Lys membranes. The spectrum of IBP
evidenced its two characteristic peaks: at 2941 cm−1 (OH bending) and
at 1703 cm−1 (C=O stretching) (Carreras et al., 2013; Yu et al., 2009).
In turn, the LO spectrum presents a broad peak at 3457 cm−1 (O–H
stretch, indicating the presence of alcohol); at 2963 cm−1 (C=C),
2924 cm−1 (stretching of methyl groups); strong bands at 1732 cm−1
(C=O), 1371 cm−1 and 1246 cm−1 (C-O) of ester groups. In addition,
it is possible to see peaks at 1008 cm−1, 919 cm−1, 833 cm−1 and
609 cm−1, which can be assigned to LO C–H deformations
(Balasubramanian and Kodam, 2014; Morgan et al., 2006).
Through the analysis of the spectra of the membranes (Fig. 2B), it is
noticeable the presence of the characteristic peaks of its raw materials
(PVA, Lys, PEO). Furthermore, the peaks of IBP and LO can also be
observed in the spectrum of PVA_Lys_IBP and PVA_Lys_LO membranes,
respectively, indicating the successful loading of these agents within the
PVA_Lys polymeric nanofibers.
3.2. Characterization of the membranes’ mechanical properties
The mechanical properties of the PVA_Lys, PVA_Lys_IBP, and
PVA_Lys_LO membranes were determined in dry and wet conditions
(Miguel et al., 2017). The Young’s modulus, tensile strength, and
elongation at break of the membranes and the values displayed by
native skin are presented in Table 2. The Young’s modulus obtained for
Table 1
Determination of the viscosity and electrical conductivity of polymeric solu-
tions used in the electrospinning process.
Polymeric
solutions




PVA_Lys 59.53 ± 2.19 943.47 ± 38.55 62.09 ± 0.13
PVA_Lys_PEO 311.97 ± 6.49 1770.75 ± 38.48 60.94 ± 0.06
PVA_Lys_IBP 222.37 ± 1.18 1315.75 ± 114.79 54.59 ± 0.05
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PVA_Lys, PVA_Lys_IBP, and PVA_Lys_LO membranes in the dry state
were 74.67 ± 10.00MPa, 72.75 ± 14.73MPa, and
44.95 ± 10.52MPa, respectively. In wet conditions these values de-
creased to 1.44 ± 0.55MPa, 2.10 ± 0.15MPa, and 0.89 ± 0.01MPa
for PVA_Lys, PVA_Lys_IBP, and PVA_Lys_LO membranes, respectively.
Further, the PVA_Lys, PVA_Lys_IBP, and PVA_Lys_LO membranes
showed values of Tensile Strength of 4.53 ± 1.02MPa,
2.78 ± 0.66MPa, and 2.89 ± 1.94MPa in dry state, and
0.31 ± 0.18MPa, 0.26 ± 0.01MPa and 0.38 ± 0.34MPa in wet
conditions, respectively. On the other side, the PVA_Lys, PVA_Lys_IBP,
and PVA_Lys_LO membranes can bear a strain of 8.18 ± 5.23%,
4.62 ± 0.27%, and 8.75 ± 6.21% for the dry state and
19.23 ± 5.13%, 14.95 ± 1.45%, and 17.00 ± 4.13% in wet state,
respectively.
The obtained results demonstrate that the drug incorporation
methodologies did not impact on the membranes mechanical beha-
viour. In fact, all the tested groups presented similar mechanical
properties (Young’s modulus, tensile strength, and elongation at break).
Further, in dry state, the mechanical parameters of the membranes are
close to those exhibited by the native skin (Table 2). (Morgado et al.,
2014) On the other side, the assays conducted under wet conditions
reveal a decrease in both the Young modulus and tensile strength for all
the tested samples. Such reduction on the membranes’ mechanical
performance under these conditions can be attributed to the highly
hydrophilic character of the membranes’ raw materials (PVA and Lys)
(Miao et al., 2017), that will prompt the interaction of membranes with
the water molecules and consequently promote its swelling and de-
creasing the intermolecular forces established between the polymeric
chains, leading to an increased molecular mobility (Sahputra et al.,
2019). Similar results were also reported for CS/PEO electrospun
membranes produced by An et al. (2009), and for CS electrospun
membranes fabricated by Li et al. (2015).
Overall, the obtained results demonstrate the suitability of the
produced membranes to provide adequate mechanical support during
Fig. 1. Characterization of the electrospun membranes (PVA_Lys, PVA_Lys_IBP and PVA_Lys_LO) morphological features. SEM images and analysis of the respective
nanofibers’ diameter distribution.
Fig. 2. ATR-FTIR analysis of the raw materials (A) and the produced electrospun membranes (B).
Table 2
Mechanical properties exhibited by the produced membranes. Data are pre-
sented as the mean ± standard deviation (n=5). The reference values for the







PVA_Lys Dry 74.67 ± 10.00 4.53 ± 1.02 8.18 ± 5.23
Wet 1.44 ± 0.55 0.31 ± 0.18 19.23 ± 5.13
PVA_Lys_IBP Dry 72.75 ± 14.73 2.78 ± 0.66 4.62 ± 0.27
Wet 2.10 ± 0.15 0.26 ± 0.01 14.95 ± 1.45
PVA_Lys_LO Dry 44.95 ± 10.52 2.89 ± 1.94 8.75 ± 6.21
Wet 0.89 ± 0.01 0.38 ± 0.34 17.00 ± 4.13
Native skin – 4.6–20 5–30 35–115
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the tissue remodelling process as well as the capacity to endure all the
mechanical stresses that membranes suffer during its handling.
3.3. Determination of the membranes’ total porosity
For skin regeneration purposes, the membranes’ porosity de-
termines their capacity to promote the exudate absorption, cell ac-
commodation, distribution of nutrients and medium, gas exchanges,
and waste excretion (Jin et al., 2013). According to the literature, a
wound dressing must present an overall porosity within the range of
60–90% for an effective healing process to occur (Chong et al., 2007;
Miguel et al., 2019b). Herein, the produced membranes presented a
total porosity value of 69.29 ± 1.54%, 77.70 ± 14.13% and
54.15 ± 3.24% for PVA_Lys, PVA_Lys_IBP, and PVA_Lys_LO mem-
branes, respectively (Fig. 3A). The obtained results revealed that the
incorporation of IBP did not affect the total porosity of the membranes,
whereas the LO adsorption at the nanofibers’ surface promoted a de-
crease on their total porosity. Such differences are also corroborated
with the structural alterations observed in the SEM images (Fig. 1).
Indeed, the nanofibers of PVA_Lys_LO membranes exhibit fibers with
higher mean diameters, increased surface roughness, and a lower
number of void spaces. Such morphological alterations have been re-
lated with a decrease on the membranes porosity (Jabur et al., 2018).
Nonetheless, all the produced membranes exhibited porosity values
within the range considered as ideal to provide the required space for
cellular accommodation, migration, nutrient exchange, and production
of new ECM.
3.4. Evaluation of the weight loss of the membranes
Traditional wound dressings need to be removed from the wound
site, in a process that can induce further lesions, increase the formation
of scar tissue as well as facilitate the wound bacterial contamination
(Jannesari et al., 2011). In this way, tissue engineering researchers have
been focused on the development of biodegradable wound dressings
that present a degradation profile compatible with the rate of new
tissue formation. Herein, the weight loss of the different membranes
was evaluated along 7 days of incubation (Fig. 3B). The results evi-
denced a more pronounced weight loss at day 1 for PVA_Lys_LO
membranes (73.79 ± 6.18%) in comparison to the PVA_Lys
(47.20 ± 7.27%) and PVA_Lys_IBP (49.53 ± 10.12%). Such differ-
ence can be attributed to the dissociation of the LO weak electrostatic
interactions (occurring between the negatively charged acetate, alde-
hyde, and terpenoid groups of LO with the amine groups of Lys) with
the surface of the PVA_Lys membrane and consequent drug release
(Gudiksen et al., 2005; Jamróz et al., 2018; Yap et al., 2014).
On the other side, the weight loss profile exhibited after 3 and
7 days of incubation is similar for the different produced membranes.
Such degradation profile of the membranes in a non-enzymatic solution
is justified by the hydrolysis of the PVA and Lys when incubated at
37 °C in PBS, simulating the in vivo conditions (Fountoulakis and Lahm,
1998; Santos et al., 2014).
3.5. Characterization of electrospun membranes’ swelling profile
During the healing process, the majority of the exudate is produced
along the inflammatory phase. The excessive accumulation of wound
exudate can induce tissue maceration, and facilitate the occurrence of
infections (Adderley, 2010). Therefore, the wound dressings must be
able to avoid the excessive accumulation of exudates as well as main-
tain a moist environment at the wound site. Herein, the membranes
capacity to adsorb fluids was characterized through the analysis of the
Fig. 3. Characterization of the porosity (A), weight loss (B) and swelling profile at pH5 (C) and at pH 8 (D) of the PVA_Lys, PVA_Lys_IBP and PVA_Lys_LO membranes.
Data are presented as the mean ± standard deviation, n=5, *p < 0.05).
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swelling profile. For that purpose, the membranes were incubated in
PBS at pH 5 (Fig. 3C) and pH 8 (Fig. 3D) to simulate the pH values of
the native and injured skin, respectively (Miguel et al., 2019b; Morgado
et al., 2014). The obtained results show that the membranes have the
maximum water uptake capacity after 24 h of incubation, for both pHs.
However, it is quite notorious that the swelling ratio for PVA_Lys,
PVA_Lys_IBP, and PVA_Lys_LO membranes was higher at pH 5 (≈18.51,
≈17.10, ≈31.14) than at pH 8 (≈15.69, ≈10.51, ≈24.68), respec-
tively. The membranes swelling behaviour is explained by the hydro-
philicity of its raw materials (PVA and Lys), as well as the protonation/
deprotonation of Lys functional groups associated with the pH varia-
tion. In fact, the Lys α-amino groups will be deprotonated at pH 8,
yielding a neutral charge (≈ 0) to the Lys molecule (Harms et al., 2008;
Nolting et al., 2007). When the membrane is incubated at pH 5, the
amino groups become protonated, leading to an increased electrostatic
repulsion between them and, consequently, facilitating the establish-
ment of stronger H-bonds with the water molecules (i.e. swelling oc-
curs) (Jesus and Redinha, 2013). Considering all the gathered data, the
swelling capacity exhibited by the membranes highlights their potential
to remove the excess of exudate during at least 50 h of incubation, thus
providing a suitable environment for the healing process to occur.
3.6. Determination of water vapor transmission rate of membranes
The wound dressings must also be permeable to moisture and gases
in order to provide the optimal environment for the healing process (Xu
et al., 2016). In this way, the determination of the membranes’ WVTR
revealed that the PVA_Lys membranes present a WVTR of
1660.75 ± 171.58mL/m2/day, whereas the PVA_Lys_IBP and PVA_-
Lys_LO membranes display a WVTR of 1572.50 ± 151.74mL/m2/day
and 1397.37 ± 220.44mL/m2/day, respectively. These data show that
the incorporation of both compounds (IBP and LO) into the PVA_Lys
membrane promote a decrease on its WVTR values. However, these
values are still superior to those presented by the majority of the
commercially available wound dressings (e.g. 285 ± 8 g/m2/day for
Comfeel (Coloplast A/S); 394 ± 12 g/m2/day for Bioclusive (Johnson-
Johnson); 792 ± 32 g/m2/day for Op Site (Smith & Nephew;
(Jonkman et al., 1988) and 120 ± 30 g/m2/day for PVA-based asym-
metric membranes (Morgado et al., 2014))). Furthermore, these results
are in agreement with other previously reported for electrospun
membranes (e.g. 1713 ± 26mL/m2/day for CS_Arginine membranes
(Antunes et al., 2015), 1762.91 ± 187.50mL/m2/day for PCL_Hya-
luronic acid/CS_zein bilayer membrane (Figueira et al., 2016), and
1353 g/m2/day for CS electrospun membranes (Naseri et al., 2014)).
3.7. Characterization of membranes’ wettability through the measurement
of water contact angles
The determination of the water contact angle (WCA) at the surface
of the electrospun membranes provide important insights about the
host tissue interaction with the material surface. According to the lit-
erature, a hydrophilic surface displays a WCA < 90°, a moderate hy-
drophilic surface present 40°<WCA < 70°, while a hydrophobic
substrate possesses a WCA > 90° (Arima and Iwata, 2007; Oliveira
et al., 2014). Herein, the PVA_Lys, PVA_Lys_IBP, and PVA_Lys_LO
membranes exhibited a WCA of 32.38 ± 2.69°, 55.05 ± 2.55° and
63.83 ± 1.43°, respectively (as can be observed in Fig. 4A). The
PVA_Lys membrane presents the lower WCA, revealing a higher hy-
drophilic character. Such feature is justified by the presence of PVA and
Lys in the composition of the membrane, which are both composed of
Fig. 4. Characterization of physicochemical of the produced membranes. Determination of the electrospun membranes’ water contact angles (A); Evaluation of the
membranes’ antioxidant activity (B); Characterization of the IBP (C) and LO (D) in vitro release profile at pH 5 and pH 8. (Data are presented as the mean ± standard
deviation, n=5, *p < 0.05, **p < 0.001, ***p < 0.0001 and ****p < 0.00001).
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highly hydrophilic groups (Miao et al., 2017). On the other side, the IBP
and LO incorporation prompted an increase on the WCA, resulting from
the hydrophobic character of the incorporated agents
(Balasubramanian and Kodam, 2014; Lowe et al., 1999). However, the
WCA values obtained for these two groups are comprehended between
40° and 70°, corresponding to a moderate hydrophilic character, which
is considered to be suitable for encouraging the cell attachment and
proliferation at the membranes’ surface (Miguel et al., 2017; Oliveira
et al., 2014).
3.8. Evaluation of the antioxidant activity of the membranes
There is a well-known relation between the inflammatory phase of
the wound healing process and the exuberant production of reactive
oxygen species (ROS). Imbalances on ROS production and their elim-
ination may originate a condition of oxidative stress, which is com-
monly observed in chronic inflammatory diseases (Pérez et al., 2017).
Thus, the ROS can trigger the pro-inflammatory cytokines secretion and
the activity of matrix metalloproteases, which degrade the ECM and
consequently impair the healing process.
In this work, the electrospun membranes were incubated with a
solution containing DPPH radicals and their radical scavenging activity
was evaluated (Fig. 4B). The PVA_Lys exhibit a radical scavenging ac-
tivity of 6.42 ± 2.94%, whereas the PVA_Lys_IBP and PVA_Lys_LO
present higher radical scavenging values, 17.68 ± 3.99% and
38.54 ± 5.58%, respectively. The IBP scavenging activity is attributed
to the phenyl group and its reactivity with the ROS (Costa et al., 2006).
Further, in in vivo conditions the IBP also decreases the ROS formation
by inhibiting the COXs (Huang et al., 2005; Van Antwerpen and Neve,
2004). In turn, the membranes containing the LO were the ones that
showed the highest antioxidant activity. The LO is an essential oil
which has been widely applied in food processing due to its antioxidant
activity, which is crucial to confer protection to food products against
oxidative rancidity (Danh et al., 2012; Yang et al., 2010). The LO’ an-
tioxidant activity arises from the presence of phenolic compounds in its
composition, which act as free radical acceptors that delay/inhibit the
autoxidation initiation step or prevents its propagation (Eça et al.,
2014; Kacániová et al., 2012).
Fig. 5. Characterization of the electrospun membranes’ biocompatibility. Analysis of the NHDF cell viability using MTS assay (A) and dsDNA content (B) after 1, 3,
and 7 days of incubation with the membranes. Data are presented as the mean ± standard deviation, n= 5, **p < 0.01, ***p < 0.001, and ****p < 0.0001. SEM
images of NHDF cells seeded at the surface of the electrospun membranes after 1, 3, and 7 days (C).
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3.9. Characterization of drug release profile of IBP and LO from nanofibers
In this study, IBP and LO were selected to be incorporated into
PVA_Lys electrospun membranes, for providing anti-inflammatory, an-
tibacterial or antioxidant properties. The EE and LE values obtained for
IBP were 84.30 ± 5.81% and 71.77 ± 7.77%, whereas for LO were
83.42 ± 2.69% and 68.63 ± 9.77%, respectively. Such results re-
vealed that both IBP and LO can be efficiently incorporated into
PVA_Lys nanofibrous membrane through the electrospinning technique
using the blend electrospinning and surface physical adsorption meth-
odologies, respectively.
Then, the IBP and LO release profiles from PVA_Lys nanofibrous
Fig. 6. Fluorescence microscopic images of a Live/Dead assay: NHDFs cultured on electrospun membranes’ surface after, 1, 3 and 7 days. Green channel: viable cells
labelled with Calcein; red channel: dead cells stained with Propidium iodide. (For interpretation of the references to color in this figure legend, the reader is referred
to the web version of this article.)
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membrane were characterized at pH 5 (found in native skin) and pH 8
(injured skin). In relation to IBP (Fig. 4C), the results show that the IBP
release from the nanofibers, at both pHs, occurred in a gradual manner
reaching its maximum after 24 h of incubation, 45.09 ± 4.02% and
29.17 ± 4.29% of IBP were released at pH 5 and pH 8, respectively.
The impact of the pH on the IBP release profile is in accordance with the
higher swelling exhibited by the membranes at pH 5, which facilitate
the drug diffusion from the nanofiber polymeric matrix to the external
media.
On the other side, the LO release profile (Fig. 4D) is characterized by
an initial burst release that occurs in the first 4 h of immersion in PBS
(44.21 ± 2.33% and 51.32 ± 1.39% at pH 5 and pH 8, respectively),
followed by a stabilization of the drug release until 48 h. The initial LO
burst release is justified by the method used to perform its incorpora-
tion into PVA_Lys membrane. In fact, the surface physical adsorption
method used just promotes the LO immobilization at the surface of the
polymeric matrix through electrostatic interactions (positively charged
amine groups of Lys and negatively charged terpene groups available
on LO structure) (Balasubramanian and Kodam, 2014; Gudiksen et al.,
2005; Jamróz et al., 2018; Yap et al., 2014). Therefore, the LO will be
immediately released from the nanofibers’ surface, which is crucial to
prevent the bacterial infections that usually occur within the first hours
after the wound dressing application (Negut et al., 2018).
3.10. Characterization of biological properties of electrospun membranes
The biological properties of the electrospun membranes were eval-
uated using the NHDF as model cells. These cells were selected due to
their pivotal role in the wound healing process (Barrientos et al., 2008).
They are responsible for the production of collagen, growth factors,
adhesive molecules, and cytokines that play active roles during the
reestablishment of the injured skin (Barrientos et al., 2008). The optical
microscopic images of NHDF cells seeded in contact with electrospun
membranes were acquired after 1, 3 and 7 days of incubation (Fig. S3).
The images show that the cell morphology was not affected by the
presence of PVA_Lys membranes, since they exhibit an elongated
morphology quite similar to cells found in the negative control (i.e. cells
incubated just with culture medium).
Additionally, the membranes’ cytotoxic profile was analysed
through the MTS assay over 1, 3, and 7 days (Fig. 5A). The obtained
data show that all the produced membranes did not induce any cyto-
toxic effect on NHDFs, over the 7 days. Further, the concentration of
IBP (1mg/mL) and LO (1.3mg/mL) incorporated into the nanofibers
did not compromise fibroblasts’ viability. Likewise, membranes’ bio-
compatibility was also corroborated by the dsDNA assay, where the
results show that no significant differences were noticed in dsDNA
content of cells in contact with membranes or just in the presence of
culture medium over a period of 7 days (Fig. 5B).
Moreover, the SEM images (Fig. 5C) highlight the bioadhesive
properties of the electrospun membranes, showing that the cells ad-
hered and spread at the surface of the membranes, along 7 days of in-
cubation. Such occur essentially due to the presence of positively
charged amine groups on Lys backbone (in membrane’ composition),
which interact with negatively charged glycosaminoglycans found in
the cell membrane (Kim et al., 2011). In fact, the Lys and their deri-
vatives have been used for coating the cell culture dishes’ surface due to
their biocompatibility, capacity to enhance cell adhesion, and relatively
good solubility in water (Wang et al., 2015).
Furthermore, the Live/Dead assays allow to characterize the cell
survival at the membranes’ surface, by simultaneously staining both
live (green labelled) and dead (red labelled) cells with Calcein and
Propidium iodide, respectively. The confocal microscopy images
(Fig. 6) demonstrated that the fibroblasts remain viable and their
number increase along time, corroborating the results obtained in the
MTS and dsDNA assays.
In addition, the cell proliferation, attachment and migration into the
Fig. 7. Confocal laser scanning microscopy (CLSM) images of NHDF cultured on the electrospun membranes’ surface (PVA_Lys, PVA_Lys_IBP and PVA_Lys_LO). Color
coded depth analysis of NHDF penetration on the membrane (red 0 μm, blue 80–100 μm) after 1 and 3 days. Blue channel: cell nuclei labelled Hoechst 33342®; red
channel: cytoplasm stained with WGA-Alexa 594®. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this
article.)
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membranes were also characterized through CLSM analysis (Fig. 7).
The results revealed that the fibroblast cells maintained a normal
phenotype and remained biologically active at the surface of electro-
spun membranes for 3 days, corroborating the data obtained through
SEM analysis. Further, the color-coded depth analysis of the membranes
indicated that fibroblasts migrated within the electrospun membranes,
with cells localized between 30 and 60 µm of depth within the mem-
branes’ polymeric matrix. Overall, the obtained data clearly demon-
strate the excellent biocompatibility of the PVA_Lys electrospun mem-
branes based-drug delivery systems, encouraging their application as a
wound dressing.
3.11. Evaluation of antimicrobial properties of electrospun membranes
An open wound provides a favourable niche for microbial coloni-
zation, which will impair the healing process. Additionally, the mi-
crobial infections are one of the main causes of the high rates of mor-
bidity and mortality found in the wound management area. So, the
development of wound dressings displaying antimicrobial activity is
crucial to avoid bacterial penetration and infections. Herein, the
membranes’ antimicrobial properties were evaluated against S. aureus
(Gram-positive bacteria) and P. aeruginosa (Gram-negative bacteria),
which are the most common microorganisms found in skin infections
(Simões et al., 2018b).
The results show that PVA_Lys membranes can impair or even
inhibit bacterial growth. The PVA_Lys, PVA_Lys_IBP, and PVA_Lys_LO
induced a bacterial growth inhibition of 34.55 ± 7.87%,
34.85 ± 4.48%, and 96.96 ± 1.84% for S. aureus, and
25.00 ± 2.90%, 21.00 ± 8.23%, and 91.18 ± 7.88% for P. aerugi-
nosa, respectively (as can be observed in Fig. 8A and B). Similar results
were observed in the agar diffusion assay, with the PVA_Lys, PVA_Ly-
s_IBP and PVA_Lys_LO membranes (Fig. 8C) presenting an inhibitory
area of 20.43 ± 5.78%, 20.49 ± 3.42% and 61.76 ± 11.75% against
S. aureus, and 0.51 ± 0.01%, 0.45 ± 0.02% and 32.77 ± 1.36% for
P. aeruginosa, respectively. Additionally, SEM images (Fig. S4) also
showed that no biofilm formation occurred at PVA_Lys, PVA_Lys_IBP
and PVA_Lys_LO membranes’ surface when samples were incubated
with S. aureus. On the other hand, when membranes were incubated
with P. aeruginosa, biofilm formation was only inhibited at the surface
of PVA_Lys_LO membrane.
These results are in agreement with the data available in the lit-
erature for LO (Cavanagh and Wilkinson, 2002; Lis-Balchin, 2003). The
LO’s antibacterial activity is justified by the presence of terpene com-
pounds (e.g. linalool, linalyl acetate, 1,8-cineole, β-ocimene, terpinen-4-
ol). Furthermore, the electronegative compounds present on LO’s
composition will also interfere on the bacteria biological processes (e.g.
electron transfer, protein translocation, phosphorylation steps) and
therefore, inhibit the growth of the microorganism (Balasubramanian
and Kodam, 2014; Yap et al., 2014). On the other hand, the essential
oils can also disrupt the bacterial cell wall and cytoplasmic membrane
Fig. 8. Evaluation of the produced PVA_Lys electrospun membranes’ antibacterial properties. Determination of the CFU/mL of S. aureus (A) and P. aeruginosa (B),
when seeded in contact with the membranes. Macroscopic images and analysis of the inhibitory halos against S. aureus and P. aeruginosa (C). Data are presented as the
mean ± standard deviation, n= 5, **p < 0.001, ****p < 0.0001.
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inducing the cell lysis and subsequent leakage of intracellular com-
pounds (Lopez-Romero et al., 2015; Sakkas et al., 2018). However, in
this work, the antibacterial activity of LO was influenced by the mi-
croorganisms’ structure, i.e., the PVA_Lys_LO presented an enhanced
antibacterial effect against S. aureus. Such result may be linked to the
composition of the cell wall on gram-negative bacteria, which is com-
posed mainly of lipopolysaccharides limiting the diffusion of hydro-
phobic compounds, such as the essential oils (Chouhan et al., 2017;
Miguel et al., 2019b). On the other side, the antibacterial activity of
PVA_Lys and PVA_Lys_IBP membranes against S. aureus can be attrib-
uted to the interaction of the positively charged amine groups of Lys
with the negatively charged groups available at the bacteria surface,
which will lead to an increased cell wall permeability and consequently
the leakage of intracellular compounds (Hyldgaard et al., 2014).
4. Conclusions
In this work, nanofibrous membranes composed of PVA and Lys
were produced using the electrospinning technique. Blend electro-
spinning was used to incorporate IBP into the membranes in order to
control the inflammatory phase (1–3 days after skin injury). On the
other hand, LO was loaded into the membranes through surface phy-
sical adsorption. Such procedure leads to an initial burst release of LO,
that provides an initial aseptic environment at the wound site, which is
crucial for avoiding the bacterial colonization. On the other side, all the
electrospun membranes presented suitable morphological, mechanical,
physicochemical and biological properties to be used as wound dres-
sings. Further, the LO incorporation on PVA_Lys membranes mediated a
strong antibacterial effect against both S. aureus and P. aeruginosa.
In the near future, the in vitro and in vivo anti-inflammatory prop-
erties of IBP will be further evaluated. Moreover, the synergic effect of
the IBP and LO incorporation into the same electrospun membrane will
be further characterized to support the application of these membranes
as multifunctional wound dressings, that can deliver anti-inflammatory
and antibacterial compounds in a time frame that match the specific
requirements of the healing process. Additionally, an alternative LO
incorporation method may be hypothesized (e.g. chemical im-
mobilization of LO at membranes’ surface) to achieve a more sustained
and prolonged drug release profile.
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